Loading...
Loading...
Browse all stories on DeepNewz
VisitNew Study Reveals Oligodendrocytes Produce Amyloid-Beta in Alzheimer's, Rescuing Neuronal Dysfunction in Mice
Jul 24, 2024, 12:15 AM
A new study published in PLOS Biology reveals that oligodendrocytes, not just neurons, produce amyloid-beta (Aβ) in Alzheimer's disease. The research, led by Marc Aurel Busche and Rikesh Rajani at the UK Dementia Research Institute (UK DRI) at UCL, demonstrates that targeting Aβ production in oligodendrocytes can rescue early neuronal dysfunction in mice. This breakthrough challenges the long-held belief that neurons are the exclusive source of pathogenic Aβ in Alzheimer's. The findings suggest new treatment avenues by focusing on suppressing oligo Aβ to mitigate neuronal damage. Additionally, secretome analysis indicates the role of oligodendrocytes in contributing to the extracellular matrix.
View original story
Markets
Yes • 50%
No • 50%
Announcements from major scientific award organizations such as the Nobel Prize, Lasker Award, or similar
Yes • 50%
No • 50%
Clinical trial databases such as ClinicalTrials.gov or announcements from major pharmaceutical companies
Yes • 50%
No • 50%
Peer-reviewed journals such as PLOS Biology, Nature, Science, or similar
Other • 25%
UK Dementia Research Institute • 25%
National Institutes of Health (NIH) • 25%
Harvard University • 25%
Publications from research institutes such as UK Dementia Research Institute, NIH, or similar
Nature • 25%
Science • 25%
PLOS Biology • 25%
Other • 25%
Publications from major scientific journals such as Nature, Science, PLOS Biology, or similar
Pfizer • 25%
Roche • 25%
Eli Lilly • 25%
Other • 25%
Announcements from major pharmaceutical companies or clinical trial databases such as ClinicalTrials.gov